Search
Certified Public Accountants
& Business Consultants

Focus On Life Sciences: MOSIRA Passes, Now Moves For Governor Signature

Contact Our Team

The Missouri Science and Innovation and Reinvestment Act (MOSIRA) has been approved by both houses of the Missouri legislature and will be sent to Governor Nixon for his signature.
September 26, 2011

The Missouri Science and Innovation and Reinvestment Act (MOSIRA) has been approved by both houses of the Missouri legislature and will be sent to Governor Nixon for his signature.

MOSIRA is landmark technology-based economic development legislation that will foster economic growth and the creation, attraction, and retention of quality jobs related to science and innovation in Missouri. It will enable Missouri to capitalize on its existing assets that make Missouri a national leader in science and innovation.

Thanks to MOSIRA, Missouri will continue its pursuit to be a leader for science and innovation entities to locate and grow in Missouri, which will create new jobs, foster economic growth, and advance scientific knowledge.

The legislation functions by capturing the new growth in state income taxes generated by new employees working in Missouri within designated science and innovation fields and reinvesting this revenue to assure future and continued growth in this important sector of Missouri’s economy.

It’s important to note that funding through the act will not involve the use of existing general revenue funds.

The MOSIRA legislation will become effective 90 days following the Governor’s signature.

To view the bill, click here.

 

Under U.S. Treasury Department guidelines, we hereby inform you that any tax advice contained in this communication is not intended or written to be used, and cannot be used by you for the purpose of avoiding penalties that may be imposed on you by the Internal Revenue Service, or for the purpose of promoting, marketing or recommending to another party any transaction or matter addressed within this tax advice. Further, RubinBrown LLP imposes no limitation on any recipient of this tax advice on the disclosure of the tax treatment or tax strategies or tax structuring described herein.

All Life Sciences News                             Life Sciences Overview

 

 

For more information, please contact: